What is the most appropriate medication for anxiety in an 83-year-old patient?

Most Appropriate Medication for Anxiety in an 83-Year-Old Patient

Start with an SSRI, specifically sertraline (25-50 mg daily) or escitalopram (5-10 mg daily), as first-line pharmacotherapy for anxiety in this 83-year-old patient. These agents have the best evidence for efficacy and safety in older adults with anxiety disorders 1, 2.

Why SSRIs Are First-Line

The most recent and highest-quality evidence strongly supports SSRIs as the preferred initial treatment:

• A 2025 meta-analysis of 2,336 older adults demonstrated that antidepressants (primarily SSRIs) significantly reduced anxiety symptoms compared to placebo (SMD -1.19), with moderate certainty of evidence 2. This represents the most comprehensive synthesis of pharmacological anxiety treatment data in older adults to date.

• Among SSRIs, sertraline and escitalopram are specifically preferred because they have fewer drug-drug interactions via cytochrome P450 enzymes—a critical consideration in an 83-year-old likely taking multiple medications 3, 1.

• Sertraline has less effect on metabolism of other medications compared to other SSRIs 3, while escitalopram/citalopram have the least effect on CYP450 isoenzymes 4.

Specific Dosing for This Age Group

Start low and go slow:

• Sertraline: 25-50 mg daily (lower than standard adult dosing) 3
• Escitalopram: 5-10 mg daily (note: avoid citalopram >20 mg daily in elderly due to QTc prolongation risk) 3

Increase doses gradually at 1-2 week intervals as tolerated. Allow 4-8 weeks for full therapeutic trial before declaring treatment failure 3, 1.

What to Absolutely Avoid

Do NOT use benzodiazepines as first-line treatment in this 83-year-old patient, despite their historical widespread use 5, 6, 7:

• The 2025 geriatric emergency guidelines found that midazolam posed an elevated risk of serious adverse events without clinical efficacy gains 8
• Benzodiazepines increase risk of cognitive impairment, falls, fractures, and delirium in older adults 5, 7
• The 2019 AGS Beers Criteria explicitly cautions against benzodiazepine use in older adults 9
• If anxiety is severe and a benzodiazepine is absolutely necessary for short-term use, lorazepam 0.25-0.5 mg is preferred (maximum 2 mg/24 hours in elderly) due to shorter half-life and no active metabolites 10

Second-Line Options If SSRIs Fail

If the patient has inadequate response to the first SSRI after an adequate trial:

1. Switch to a different SSRI or try an SNRI (venlafaxine or duloxetine) 1
2. Consider pregabalin/gabapentin as third-line options, though these require renal dose adjustment and carry risks of fluid retention 11, 1
3. Buspirone (5 mg twice daily, maximum 20 mg three times daily) may be useful for mild-moderate anxiety in relatively healthy older adults, particularly if avoiding sexual side effects is a priority 3, 1. However, it takes 2-4 weeks to become effective 3

Critical Safety Considerations

Monitor for these specific risks in an 83-year-old:

• QTc prolongation: Avoid citalopram >20 mg daily (ideally use escitalopram instead); check baseline ECG if using any SSRI with QTc risk 4
• Hyponatremia/SIADH: SSRIs can cause this, particularly in older adults 9
• Falls risk: All psychotropic medications increase fall risk; ensure home safety assessment
• Drug interactions: Review all medications for CYP450 interactions, particularly if patient takes warfarin, tamoxifen, or other drugs metabolized by CYP2D6 4
• Discontinuation syndrome: If switching SSRIs, taper over 10-14 days, especially with paroxetine, fluvoxamine, or sertraline 4, 3

What About Antipsychotics?

Avoid antipsychotics unless anxiety is part of severe agitation or psychosis. Quetiapine is sometimes used for refractory anxiety 1, but antipsychotics carry a black box warning for increased mortality in elderly patients with dementia 5. The 2025 geriatric emergency guidelines found oral quetiapine had the best safety profile among antipsychotics when needed for severe agitation 8, but this should not be extrapolated to routine anxiety treatment.

Algorithm Summary

1. First-line: Sertraline 25-50 mg daily OR escitalopram 5-10 mg daily
2. Wait 4-8 weeks for adequate trial
3. If partial response: Increase dose gradually
4. If no response: Switch to different SSRI or SNRI (venlafaxine/duloxetine)
5. If still inadequate: Consider pregabalin/gabapentin or buspirone
6. Reserve benzodiazepines only for severe, acute situations requiring immediate anxiolysis, using lowest effective dose for shortest duration

The evidence overwhelmingly supports SSRIs as both safer and more effective than benzodiazepines for sustained anxiety management in older adults, with the 2025 meta-analysis providing the strongest contemporary evidence base 2.